Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Cancer Gene Therapy|May 14, 2005
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancersTrine Lillehammer, Siri Tveito, Birgit O Engesaeter, et al.
The Journal of Gene Medicine|March 7, 2006
Photochemical treatment with endosomally localized photosensitizers enhances the number of adenoviruses in the nucleusBirgit Ø Engesaeter, Siri Tveito, Anette Bonsted, et al.
The Journal of Gene Medicine|April 6, 2007
Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell linesTrine Lillehammer, Birgit O Engesaeter, Lina Prasmickaite, et al.
Cancer Biology & Therapy|October 3, 2006
Photochemically mediated delivery of AdhCMV-TRAIL augments the TRAIL-induced apoptosis in colorectal cancer cell linesBirgit Ø Engesaeter, Anette Bonsted, Trine Lillehammer, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 6, 2009
Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sitesGunhild M Maelandsmo, Vivi Ann Flørenes, Mai T P Nguyen, et al.
American Journal of Clinical Pathology|September 15, 2004
Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcomeVivi Ann Flørenes, Gunhild M Maelandsmo, Ruth Holm, et al.
Biochimie|September 8, 2015
Nuclear cathepsin L activity is required for cell cycle progression of colorectal carcinoma cellsTripti Tamhane, Rukshala Lllukkumbura, Shiying Lu, et al.
The Journal of Surgical Research|August 9, 2005
Matrix metalloproteinases participate in osteosarcoma invasionKristin Bjørnland, Kjersti Flatmark, Solveig Pettersen, et al.
Scientific Reports|April 7, 2019
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer SubtypesAnna Barkovskaya, Kotryna Seip, Bylgja Hilmarsdottir, et al.
Oncogene|August 15, 2003
Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradationJørn Henriksen, Trude H Aagesen, Gunhild M Maelandsmo, et al.
Pageof 6